Delisting riskPopularity #4,022
JAGX · NASDAQ · Biotechnology

Jaguar Health (JAGX)

Develops and supplies crofelemer treatments for intestinal failure and diarrhea in people and animals.

$8.89
vs last close−25.57 (−74.20%)